about
Clinical course of sly syndrome (mucopolysaccharidosis type VII)Health-related quality of life in mucopolysaccharidosis: looking beyond biomedical issuesAnaesthesia and airway management in mucopolysaccharidosis.Radiological and clinical characterization of the lysosomal storage disorders: non-lipid disordersEffects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type IEvaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII.Pentosan polysulfate: a novel therapy for the mucopolysaccharidosesDose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatmentCNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)Boning up on autophagy: the role of autophagy in skeletal biologyRespiratory and sleep disorders in mucopolysaccharidosisDecreased performance in IDUA knockout mouse mimic limitations of joint function and locomotion in patients with Hurler syndromeAssessment of musculoskeletal abnormalities in children with mucopolysaccharidoses using pGALSChondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo.The effect of Tlr4 and/or C3 deficiency and of neonatal gene therapy on skeletal disease in mucopolysaccharidosis VII mice.Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome.Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT).Adverse Effects of Genistein in a Mucopolysaccharidosis Type I Mouse ModelA review of gene therapy in canine and feline models of lysosomal storage disorders.Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.C-Type Lectin Receptor Dectin-2 Binds to an Endogenous Protein β-Glucuronidase on Dendritic CellsIdentification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type IIAn introduction to proteoglycans and their localizationResidual N-acetyl-α-glucosaminidase activity in fibroblasts correlates with disease severity in patients with mucopolysaccharidosis type IIIBMucopolysaccharidosis I; Parental beliefs about the impact of disease on the quality of life of their children.Development of a Scoring System to Evaluate the Severity of Craniocervical Spinal Cord Compression in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome).The diagnostic journey of patients with mucopolysaccharidosis I: A real-world survey of patient and physician experiences.Glycan-based biomarkers for mucopolysaccharidoses.Pregnancy in patients with mucopolysaccharidosis: a case seriesParents' experiences of living with, and caring for children, adolescents and young adults with Mucopolysaccharidosis (MPS).Murine neural stem cells model Hunter disease in vitro: glial cell-mediated neurodegeneration as a possible mechanism involved.Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose.Cardiovascular Abnormalities in Egyptian Children with Mucopolysaccharidoses.Factors and processes modulating phenotypes in neuronopathic lysosomal storage diseases.Skeletal Dysplasias: Growing Therapy for Growing Bones.Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain.Diagnosis of the mucopolysaccharidoses.Animal models for metabolic, neuromuscular and ophthalmological rare diseases.Lysosomal storage diseases--the horizon expands.Mucopolysaccharidoses.
P2860
Q24658556-3A95F0B8-92B7-46ED-A21D-77206A742E2CQ26738901-79E17CA1-EF6C-48AE-AEE5-397B0A1CDBB9Q26996429-8176B8DF-0692-4107-86B5-909D5EFFFB6DQ27027867-6643A691-C99A-4F12-9058-8E27A96F9592Q27316418-193E3B04-AF2A-4E85-BFD3-6F6E3C8CF91DQ27318087-06DF6496-8470-4CEB-99F7-D8A39F9195C8Q27319509-D0A46D64-7D17-49A2-BCFA-712D8831B12EQ27321536-B9581C4F-39F2-4DF8-BB9A-8808FA5209A5Q27333793-2A0933F2-B35E-4AC9-BA56-6042AB799B53Q28659840-69C0C313-2FDD-4C1E-88B4-E50A8F820CD7Q30457547-3ADAEF2B-7829-48C6-85F5-CAB2C2201AE5Q30665510-9F5828BA-D5C9-45C1-90C1-AF03E4431478Q34018538-BA748914-FD6E-4EA2-BDF6-8208059313F0Q34440312-9FE80447-6588-4ED1-9FF7-1BBECFB34CE3Q35237967-5FAA398B-D0CC-4704-A261-CB11A6F7604BQ35669546-23E3B9A1-945B-45CF-8106-AB4C00721F41Q35693912-7DB68CFA-A662-47D1-8930-CCA0E14568DAQ35795405-4C4062EB-9490-4CDE-8BDE-0816B6A5BFFAQ35894676-02C1E47D-8FA7-48C2-ABC8-1D290CC504E2Q36219639-B2C62F26-A72E-4B16-946C-6F322633558EQ36238416-B0987B51-D255-41AA-8447-676C8CEB5F4FQ36282902-A0A3F527-DD4F-4A33-9F41-979315C9F394Q36481630-DEFAC9A6-3C40-4A21-B001-7A43ECD071FBQ36853478-979755BC-0273-4294-8E1B-206DD63C4597Q37089858-89CEF613-1D93-48B3-8565-53BAD2076964Q37127620-3B63549A-CEEB-4741-BBD0-7D55E411C73AQ37156166-C6FC639F-B285-4841-9830-9EF650D4696CQ37161285-8A131CA4-2733-4A4C-AACB-8D853A62EADCQ37224435-AA9F7E9B-99FF-4399-BCE6-D52FD57DC3ABQ37325706-287FC99E-BC50-4DC8-989F-48FAEE490B48Q37357050-265480E8-1FDC-4FD7-AD22-C46CAE5AED9AQ37515209-3EC8E24D-20FB-4E5E-B69B-A35DA62EA937Q37543239-7A10803C-742B-4658-AB32-630EF2ED58C3Q37595934-22B542BA-72DF-45E5-9AA4-30C4AE23E1EFQ37681118-8730C383-FEB4-4067-A7BB-C60C789E8AE5Q37698448-F8DC91A0-258C-40BD-B158-A6A705AC79D1Q37972590-CADE7134-9DB0-4680-9A6E-A53EC2B9D0AAQ38089518-1BA916A6-F3C8-47B0-AB6C-2EA77A5234C9Q38128478-CDA8282F-784F-4D30-8095-62D576396AE8Q38165092-273C5E62-A254-4883-9CBD-A095106CBDB6
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Overview of the mucopolysaccharidoses.
@en
Overview of the mucopolysaccharidoses.
@nl
type
label
Overview of the mucopolysaccharidoses.
@en
Overview of the mucopolysaccharidoses.
@nl
prefLabel
Overview of the mucopolysaccharidoses.
@en
Overview of the mucopolysaccharidoses.
@nl
P2860
P356
P1433
P1476
Overview of the mucopolysaccharidoses.
@en
P2093
Joseph Muenzer
P2860
P356
10.1093/RHEUMATOLOGY/KER394
P478
50 Suppl 5
P577
2011-12-01T00:00:00Z